What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Enzyme
- Botany
Olov Sterner mainly focuses on Stereochemistry, Biochemistry, Biological activity, Microbiology and Sesquiterpene.
His Stereochemistry study combines topics in areas such as Phloroglucinol and GABAA receptor.
His study brings together the fields of Pyrene and Biochemistry.
His Biological activity research is multidisciplinary, incorporating perspectives in Antimicrobial, Antibacterial agent and Enzyme.
His research integrates issues of Fermentation, Cell biology, Hohenbuehelia and Lactarius in his study of Microbiology.
His Sesquiterpene study incorporates themes from Vanilloids and Capsaicin.
His most cited work include:
- Pungent products from garlic activate the sensory ion channel TRPA1 (668 citations)
- TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol (205 citations)
- Endogenous Unsaturated C18 N-Acylethanolamines Are Vanilloid Receptor (TRPV1) Agonists (151 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Stereochemistry, Organic chemistry, Biochemistry, Biological activity and Botany.
Olov Sterner interconnects Antimicrobial and Fungus in the investigation of issues within Stereochemistry.
His Antimicrobial study is focused on Microbiology in general.
His Cell culture research extends to the thematically linked field of Biochemistry.
He has researched Biological activity in several fields, including Metabolite, Antibacterial agent and Cytotoxicity.
His Sesquiterpene study frequently involves adjacent topics like Lactarius.
He most often published in these fields:
- Stereochemistry (38.24%)
- Organic chemistry (18.51%)
- Biochemistry (18.34%)
What were the highlights of his more recent work (between 2010-2021)?
- Stereochemistry (38.24%)
- Organic chemistry (18.51%)
- Traditional medicine (6.57%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Stereochemistry, Organic chemistry, Traditional medicine, Botany and Phytochemical.
His Stereochemistry research includes themes of Biosynthesis and Cytotoxicity.
The various areas that Olov Sterner examines in his Cytotoxicity study include Metabolite, Biological activity and Lactone.
In his research on the topic of Organic chemistry, Tannin, Lipid peroxidation and Antioxidant is strongly related with Chromatography.
In general Botany study, his work on Calotropis procera and Medicinal plants often relates to the realm of Bourreria pulchra, thereby connecting several areas of interest.
Biochemistry covers Olov Sterner research in DNA.
Between 2010 and 2021, his most popular works were:
- TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol (205 citations)
- Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells. (73 citations)
- Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells (59 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Enzyme
- Botany
Olov Sterner mainly investigates Cell growth, Molecular biology, DU145, Prostate cancer and Pharmacology.
His work deals with themes such as Apoptosis, Cell cycle and Cell culture, which intersect with Cell growth.
Olov Sterner studied Apoptosis and Epimer that intersect with DNA, Terpenoid and Biochemistry.
His biological study spans a wide range of topics, including Systemic administration and Receptor, Cannabinoid, Noxious stimulus, Nociception.
His work in Central nervous system addresses issues such as Binding site, which are connected to fields such as Stereochemistry.
Olov Sterner focuses mostly in the field of Stereochemistry, narrowing it down to topics relating to Organic chemistry and, in certain cases, Botany.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
